Amicus Therapeutics Announces Presentations and Posters at the 17th Annual WORLDSymposium™ 2021
CRANBURY, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused…
Börse:
16,950€
1,50%
Echtzeit-Aktienkurs Amicus Therapeutics Inc.
Bid:
16,900€
Ask:
17,000€
Nachrichten zur Amicus Therapeutics Inc. Aktie
Amicus Therapeutics reports preliminary 2020 revenue and 2021 outlook
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AMICUS THERAPEUTICS, INC.: 8-K Report
FORM 8-K...…
Amicus Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
CRANBURY, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley,…
Microsoft, Google, Cisco, Dell join legal battle against hacking company NSO
Tech giants including Microsoft and Google on Monday joined Facebooks legal battle against hacking company NSO, filing an amicus brief…
Google, Cisco, and VMware join Microsoft to oppose NSO Group in WhatsApp spyware case
A coalition of companies have filed an amicus brief in support of a legal case brought by WhatsApp against Israeli…
Microsoft, Google, Cisco, VMware join legal battle against hacking company NSO
Tech giants Microsoft, Alphabet , Cisco, and VMware on Monday joined Facebooks legal battle against hacking company NSO, filing an…
Sarepta, Amicus Top Biotech Picks Ahead Of Key Binary Events: Analyst
Biopharma stocks are risky investment bets that sway wildly in reaction to catalytic events. Binary events scheduled for Amicus Therapeutics,…
Amicus Therapeutics (FOLD) Catches Eye: Stock Jumps 8.1%
Amicus Therapeutics (FOLD) saw a big move last session, as its shares jumped more than 8% on the day, amid…
House Democrat Calls To Exclude 126 Republicans From Next Congress For Supporting Texas Lawsuit
Rep. Bill Pascrell urged Speaker Nancy Pelosi to refuse to seat anyone who signed an amicus brief in support of…
Amicus Therapeutics Named a Great Place to Work-Certified™ Company in 2020
CRANBURY, N.J., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused…
Amicus (FOLD) Initiates Rolling BLA Submission for AT-GAA
Amicus (FOLD) initiates a rolling biologics license application (BLA) submission to the FDA for AT-GAA, for the treatment of late…
AMICUS THERAPEUTICS, INC.: 8-K Report
FORM 8-K...…
Amicus Therapeutics Appoints Michael A. Kelly to its Board of Directors
CRANBURY, N.J., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced the election and appointment…
Gray Files Supreme Court Brief Supporting Modernized Television Station Ownership Rules
Atlanta, Georgia, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Gray Television, Inc. (“Gray,” “we,” or “our”) (NYSE: GTN) announced…
Amicus Therapeutics (FOLD) Presents At Credit Suisse 29th Annual Virtual Healthcare Conference - Slideshow
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amicus Therapeutics, Inc. (FOLD) CEO John Crowley on Q3 2020 Results - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amicus Therapeutics (FOLD) Reports Q3 Loss, Tops Revenue Estimates
Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of -10.00% and 3.69%, respectively, for the quarter ended September 2020. Do…
Amicus Therapeutics, Inc. 2020 Q3 - Results - Earnings Call Presentation
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amicus Therapeutics EPS misses by $0.04, beats on revenue
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AMICUS THERAPEUTICS, INC.: 8-K Report
FORM 8-K...…
Amicus Therapeutics to Present at the Credit Suisse 29th Annual Virtual Healthcare Conference
CRANBURY, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley,…
Amicus Therapeutics (FOLD) Investor Presentation - Slideshow
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amicus Therapeutics (FOLD) Presents Interim Data for CLN6 Gene Therapy at Child Neurology Society Meet - Slideshow
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amicus Therapeutics Announces Additional Positive Interim Clinical Data for CLN6 Batten Disease Gene Therapy at 49th Annual Meeting of the Child Neurology Society
Data Continue to Support Meaningful Effect on Motor and Language Function in Children with Fatal Neurologic Disease Data Continue to…
Amicus Therapeutics: Inflection Point Coming In 2021
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amicus Therapeutics receives PRIME designation for CLN6 batten disease gene therapy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amicus Therapeutics Receives European Medicines Agency PRIME Designation for CLN6 Batten Disease Gene Therapy
Additional Phase 1/2 Data to be Presented at the Child Neurology Society Annual Meeting in October Additional Phase 1/2 Data…
Amicus Therapeutics (FOLD) Investor Presentation - Slideshow
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amicus Therapeutics (FOLD) Down 7.5% Since Last Earnings Report: Can It Rebound?
Amicus Therapeutics (FOLD) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2020
CRANBURY, N.J., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the…
Tech Company Amicus Brief Makes A Strong Case For Immigration
Americas most successful companies say they owe their success to being open to talented people from around the world....…
Amicus Therapeutics Inc (FOLD) Q2 2020 Earnings Call Transcript
FOLD earnings call for the period ending June 30, 2020....…
AMICUS THERAPEUTICS, INC.: 10-Q Report
10-Q...…
Amicus Therapeutics, Inc. (FOLD) CEO John Crowley on Q2 2020 Results - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amicus Therapeutics, Inc. 2020 Q2 - Results - Earnings Call Presentation
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amicus Therapeutics (FOLD) Reports Q2 Loss, Misses Revenue Estimates
Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of 23.08% and -0.48%, respectively, for the quarter ended June 2020. Do…
Recap: Amicus Therapeutics Q2 Earnings
Shares of Amicus Therapeutics (NASDAQ:FOLD) rose 0.6% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased…
AMICUS THERAPEUTICS, INC.: 8-K Report
FORM 8-K...…
Will Amicus Therapeutics (FOLD) Report Negative Earnings Next Week? What You Should Know
Amicus Therapeutics (FOLD) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…
AMICUS THERAPEUTICS, INC.: 8-K Report
FORM 8-K...…
Amicus Therapeutics to Announce Second Quarter 2020 Financial Results on August 10, 2020
CRANBURY, N.J., July 28, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will…
IN BRIEF: BioPharma Credit To Ink USD156.2 Million From Amicus
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Amicus Therapeutics secures $400M in debt financing
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AMICUS THERAPEUTICS, INC.: 8-K Report
8-K...…
Amicus Therapeutics Secures $400 Million Non-Dilutive Debt Financing
$400M Debt Facility Provides Path to Profitability Without the Need for Any Future Dilutive Financings...…
Amicus Therapeutics: 2 Potential Blockbusters Make This Stock Worth Considering
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amicus Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
CRANBURY, N.J., June 04, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley,…
Twitter, Reddit challenge US rules forcing visa applicants to disclose their social media handles
Twitter and Reddit have filed an amicus brief in support of a lawsuit challenging a U.S. government rule change compelling…
Amicus Therapeutics, Inc. (FOLD) CEO John Crowley on Q1 2020 Results - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…